nach oben

Erschienen in:

07.09.2019 | Original Article

The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study

verfasst von: Raquel Manso-Calderón, Purificación Cacabelos-Pérez, María D. Sevillano-García, María E. Herrero-Prieto, Rogelio González-Sarmiento

Erschienen in: Neurological Sciences | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Behavioural and psychological symptoms (BPS) worsen quality of life and increase institutionalization in dementia, but the relationship between BPS and vascular burden on neuroimaging is unclear. Our aim is to explore whether the profile of BPS differs between patients with large-vessel or cortical vascular dementia (cVaD), small-vessel or subcortical vascular dementia (sVaD) and Alzheimer’s disease (AD).

Methods

The BEVASDE study comprised 806 demented patients (cVaD—136, sVaD—184, AD—486) recruited from outpatient consultations in Salamanca and Avila, Spain. The Clinical Dementia Rating Scale (CDR) and the 12-item Neuropsychiatric Inventory (NPI) were used to evaluate dementia severity and BPS.

Results

BPS were reported in 98.5%, 97.3% and 96.9% of the cVaD, sVaD and AD cases, respectively. The median NPI score was 36 in both cVaD and sVaD and 34 in AD, with a median number of four symptoms per patient. The most frequent disorders were depression (64.4%), apathy (61.8%) and sleep disturbance (60.5%). Multivariate regression analyses after controlling for possible confounders showed a higher risk of euphoria (p = 0.011), apathy (p = 0.007), irritability (p = 0.002) and sleep disturbance (p = 0.020) in cVaD than in AD and more apathy (p = 0.0001) and irritability (p = 0.0001) in sVaD than in AD. In contrast, AD subjects had a higher risk of delusions (p = 0.007) and hallucinations (p = 0.023) than patients with cVaD as well as more aberrant motor behaviour than both cVaD (p = 0.0001) and sVaD (p = 0.003).

Conclusion

BPS are common in dementia and may help in differential diagnosis of the various subtypes. We should inquire about them and treat as necessary.

Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC (2000) Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry 157:708–714. https://doi.org/10.1176/appi.ajp.157.5.708 CrossRefPubMed

Srikanth S, Nagaraja AV, Ratnavalli E (2005) Neuropsychiatric symptoms in dementia frequency, relationship to dementia severity and comparison in Alzheimer’s disease, vascular dementia and frontotemporal dementia. J Neurol Sci 236:43–48. https://doi.org/10.1016/j.jns.2005.04.014 CrossRefPubMed

Finkel SI (2001) Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry 62(Suppl 21):P3–P6

Kim JM, Lyons D, Shin IS, Yoon JS (2003) Differences in the behavioral and psychological symptoms between Alzheimer’s disease and vascular dementia: are the different pharmacologic treatment strategies justifiable? Hum Psychopharmacol 18:215–220. https://doi.org/10.1002/hup.466 CrossRefPubMed

Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260CrossRefPubMed

Ikeda M, Fukuhara R, Shigenobu K, Hokoishi K, Maki N, Nebu A, Komori K, Tanabe H (2004) Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry 75:146–148PubMedPubMedCentral

Hsieh CJ, Chang CC, Lin CC (2009) Neuropsychiatric profiles of patients with Alzheimer’s disease and vascular dementia in Taiwan. Int J Geriatr Psychiatry 24:570–577. https://doi.org/10.1002/gps.2156 CrossRefPubMed

D’Onofrio G, Sancarlo D, Panza F, Copetti M, Cascavilla L, Paris F, Seripa D, Matera MG, Solfrizzi V, Pellegrini F, Pilotto A (2012) Neuropsychiatric symptoms and functional status in Alzheimer’s disease and vascular dementia patients. Curr Alzheimer Res 9:759–771CrossRefPubMed

Aharon-Peretz J, Kliot D, Tomer R (2000) Behavioral differences between white matter lacunar dementia and Alzheimer’s disease: a comparison on the neuropsychiatric inventory. Dement Geriatr Cogn Disord 11:294–298. https://doi.org/10.1159/000017252 CrossRefPubMed

10.

Caputo M, Monastero R, Mariani E, Santucci A, Mangialasche F, Camarda R, Senin U, Mecocci P (2008) Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand 117:455–464. https://doi.org/10.1111/j.1600-0447.2008.01175.x CrossRefPubMed

11.

Fernández-Martínez M, Castro J, Molano ZJJ, Rodrigo RM, Ortega R (2008) Prevalence of neuropsychiatric symptoms in Alzheimer’s disease and vascular dementia. Curr Alzheimer Res 5:61–69CrossRefPubMed

12.

Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288:1475–1483CrossRefPubMed

13.

Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST (2003) Vascular cognitive impairment. Lancet Neurol 2:89–98CrossRef

14.

Moretti R, Torre P, Antonello RM, Cazzato G (2006) Behavioral alterations and vascular dementia. Neurologist 12:43–47. https://doi.org/10.1097/01.nrl.0000186806.54314.e8 CrossRefPubMed

15.

Fuh JL, Wang SJ, Cummings JL (2005) Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry 76:1337–1341. https://doi.org/10.1136/jnnp.2004.056408 CrossRefPubMedPubMedCentral

16.

Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, Barkhof F, van der Flier WM (2010) Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry 81:547–551. https://doi.org/10.1136/jnnp.2009.187500 CrossRefPubMed

17.

Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314CrossRefPubMed

18.

Steinberg M, Corcoran C, Tschanz JT, Huber C, Welsh-Bohmer K, Norton MC, Zandi P, Breitner JC, Steffens DC, Lyketsos CG (2006) Risk factors for neuropsychiatric symptoms in dementia: the Cache County study. Int J Geriatr Psychiatry 21:824–830. https://doi.org/10.1002/gps.1567 CrossRefPubMed

19.

Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-Mental State’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed

20.

Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412–2414CrossRefPubMed

21.

Vilalta-Franch J, Lozano-Gallego M, Hernández-Ferrándiz M, Llinàs-Reglà J, López-Pousa S, López OL (1999) The neuropsychiatric inventory. Psychometric properties of its adaptation into Spanish. Rev Neurol 29:15–19PubMed

22.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269. https://doi.org/10.1016/j.jalz.2011.03.005 CrossRefPubMedPubMedCentral

23.

van Straaten EC, Scheltens P, Knol DL, van Buchem MA, van Dijk EJ, Hofman PA, Karas G, Kjartansson O, de Leeuw FE, Prins ND, Schmidt R, Visser MC, Weinstein HC, Barkhof F (2003) Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 34:1907–1912. https://doi.org/10.1161/01.SRT.0000083050.44441.10 CrossRefPubMed

24.

Chiu PY, Liu CH, Tsai CH (2007) Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia. Acta Neurol Taiwanica 16:86–91

25.

Scaricamazza E, Colonna I, Sancesario GM, Assogna F, Orfei MD, Franchini F, Sancesario G, Mercuri NB, Liguori C (2019) Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer’s disease patients: a retrospective observational study. Neurol Sci 40(7):1377–1382CrossRefPubMed

26.

De Carolis A, Cipollini V, Donato N, Sepe-Monti M, Orzi F, Giubilei F (2017) Cognitive profiles in degenerative dementia without evidence of small vessel pathology and small vessel vascular dementia. Neurol Sci 38(1):101–107CrossRefPubMed

27.

Zamboni G, Huey ED, Krueger F, Nichelli PF, Grafman J (2008) Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology 71:736–742. https://doi.org/10.1212/01.wnl.0000324920.96835.95 CrossRefPubMedPubMedCentral

28.

Jorge RE, Starkstein SE, Robinson RG (2010) Apathy following stroke. Can J Psychiatr 55:350–354. https://doi.org/10.1177/070674371005500603 CrossRef

29.

Reyes S, Viswanathan A, Godin O, Dufouil C, Benisty S, Hernandez K, Kurtz A, Jouvent E, O'Sullivan M, Czernecki V, Bousser MG, Dichgans M, Chabriat H (2009) Apathy: a major symptom in CADASIL. Neurology 72:905–910. https://doi.org/10.1212/01.wnl.0000344166.03470.f8 CrossRefPubMed

30.

Spalletta G, Cravell L, Piras F, Iorio M, Sancesario G, Marchi A, Caltagirone C, Cacciari C (2013) Rapid-onset apathy may be the only clinical manifestation after dorsal striatum hemorrhagic lesion: a case report. Alzheimer Dis Assoc Disord 27(2):192–194CrossRefPubMed

31.

van Dalen JW, Moll van Charante EP, Nederkoorn PJ, van Gool WA, Richard E (2013) Poststroke apathy. Stroke 44(3):851–860. https://doi.org/10.1161/STROKEAHA.112.674614 CrossRefPubMed

32.

Koenigs M, Holliday J, Solomon J, Grafman J (2010) Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci 30:16041–16043. https://doi.org/10.1523/JNEUROSCI.3745-10.2010 CrossRefPubMedPubMedCentral

33.

Chen YK, Lu JY, Mok VC, Ungvari GS, Chu WC, Wong KS, Tang WK (2011) Clinical and radiologic correlates of insomnia symptoms in ischemic stroke patients. Int J Geriatr Psychiatry 26:451–457. https://doi.org/10.1002/gps.2547 CrossRefPubMed

34.

Terzoudi A, Vorvolakos T, Heliopoulos I, Livaditis M, Vadikolias K, Piperidou H (2009) Sleep architecture in stroke and relation to outcome. Eur Neurol 61:16–22. https://doi.org/10.1159/000165344 CrossRefPubMed

35.

Cummings JL, Arciniegas DB, Brooks BR, Herndon RM, Lauterbach EC, Pioro EP, Robinson RG, Scharre DW, Schiffer RB, Weintraub D (2006) Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 11:1–7CrossRefPubMed

36.

Tang WK, Chen YK, Lu JY, Mok VC, Xiang YT, Ungvari GS, Ahuja AT, Wong KS (2009) Microbleeds and post-stroke emotional lability. J Neurol Neurosurg Psychiatry 80:1082–1086. https://doi.org/10.1136/jnnp.2009.175372 CrossRefPubMed

37.

Reilly TJ, Staff RT, Ahearn TS, Bentham P, Wischik CM, Murray AD (2011) Regional cerebral blood flow and aberrant motor behaviour in Alzheimer’s disease. Behav Brain Res 222:375–379. https://doi.org/10.1016/j.bbr.2011.04.003 CrossRefPubMed

38.

Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL (2005) Neuroanatomical correlates of behavioural disorders in dementia. Brain 128:2612–2625. https://doi.org/10.1093/brain/awh628 CrossRefPubMed

39.

Rolland Y, Payoux P, Lauwers-Cances V, Voisin T, Esquerré JP, Vellas B (2005) A SPECT study of wandering behavior in Alzheimer’s disease. Int J Geriatr Psychiatry 20:816–820. https://doi.org/10.1002/gps.1362 CrossRefPubMed

40.

Machulda MM, Jones DT, Vemuri P, McDade E, Avula R, Przybelski S, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr (2011) Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol 68:1131–1136. https://doi.org/10.1001/archneurol.2011 CrossRefPubMedPubMedCentral

41.

Geda YE, Schneider LS, Gitlin LN, Miller DS, Smith GS, Bell J, Neuropsychiatric Syndromes Professional Interest Area of ISTAART et al (2013) Neuropsychiatric symptoms in Alzheimer’s disease: past progress and anticipation of the future. Alzheimers Dement 9(5):602–608. https://doi.org/10.1016/j.jalz.2012.12.001 CrossRefPubMedPubMedCentral

42.

Weissberger GH, Melrose RJ, Narvaez TA, Harwood D, Mandelkern MA, Sultzer DL (2011) 18F-Fluorodeoxyglucose positron emission tomography cortical metabolic activity associated with distinct agitation behaviors in Alzheimer disease. Am J Geriatr Psychiatry 25(6):569–579. https://doi.org/10.1016/j.jagp.2017.01.017 CrossRef

43.

Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL (1999) Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord 10:130–138CrossRefPubMed

44.

Johnson DK, Watts AS, Chapin BA, Anderson R, Burns JM (2011) Neuropsychiatric profiles in dementia. Alzheimer Dis Assoc Disord 25(4):326–332CrossRefPubMedPubMedCentral

45.

Aalten P, de Vugt ME, Lousberg R, Korten E, Jaspers N, Senden B, Jolles J, Verhey FR (2003) Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord 15(2):99–105CrossRefPubMed

46.

Cravello L, Palmer K, de Girolamo G, Caltagirone C, Spalletta G (2011) Neuropsychiatric symptoms and syndromes in institutionalized elderly people without dementia. Int Psychogeriatr 23(3):425–434CrossRefPubMed

47.

van der Linde RM, Dening T, Matthews FE, Brayne C (2014) Grouping of behavioural and psychological symptoms of dementia. Int J Geriatr Psychiatry 29(6):562–568CrossRefPubMed

Titel: The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study
verfasst von: Raquel Manso-Calderón
Purificación Cacabelos-Pérez
María D. Sevillano-García
María E. Herrero-Prieto
Rogelio González-Sarmiento
Publikationsdatum: 07.09.2019
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 1/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-04071-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study

Abstract

Objectives

Methods

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Checkpointhemmer auch bei MS sicher

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

High HbA1c level is correlated with blood-brain barrier disruption in syphilis patients

Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene—case series

Tracking cognitive impairment in multiple sclerosis using the Brain on Track test: a validation study

Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia—an observational study

Correction to: Aging with multiple sclerosis: prevalence and profile of cognitive impairment

Diffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Checkpointhemmer auch bei MS sicher

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Neurologie